Research News
A consortium led by GW has been refunded for their BioCompute Object Specification Project, thanks to a $2.2 million, five-year grant from the U.S. Food and Drug Administration.
Each year, close to 3 million Traumatic Brain Injury (TBI)-related emergencies arrive at hospitals and ambulatory care centers across the country, according to the Centers for Disease Control. While many of those are relatively minor, stemming...
Robert W. Turner II has a doctorate in sociology from the City University of New York, but his most significant degree was earned at the School of Hard Knocks — more familiarly known as professional football. Turner, assistant professor of...
Could the brain provide biological clues following a traumatic injury that would improve the outcome for the patient?
In early 2018, a woman in her 30s, we’ll call her Sue although that’s not her real name, decided that she’d like to try one of those hip electric scooters she’d seen whizzing around town. Bad decision. Unprepared for sharp turns and close...
A joint group of researchers at the George Washington University and the University of Pittsburgh have found that dopamine and the dopamine D2 receptor modulate expression via the Wnt/β-catenin signaling pathway. This pathway is responsible for...
A research team including Michael Bukrinsky, MD, PhD, from the GW School of Medicine and Health Sciences published in PLOS Pathogens on the role of an HIV protein in causing metabolic comorbidities.
A research collaborative including the GW, Transcultural Psychosocial Organization Nepal, Tribhuvan University Teaching Hospital, Epidemiology and Disease Control Division of the Ministry of Health and Population of Nepal, Duke University, and...
In a research paper in the American Journal of Men’s Health, Robert Turner II, PhD, assistant professor of clinical research and leadership, sought to expand upon investigations into risks for depressive symptoms in former athletes in the NFL....
In a new paper published in Seminars in Arthritis and Rheumatism, researchers from GW evaluated the long-term outcomes for patients with juvenile idiopathic inflammatory myopathies.
